Guggenheim initiated coverage on Alpine Immune Sciences with a new price target
$ALPN
Biotechnology: Pharmaceutical Preparations
Health Care
Guggenheim initiated coverage of Alpine Immune Sciences with a rating of Buy and set a new price target of $55.00